- Home
- ADCT vs EBMT Comparison
ADCT vs EBMT Comparison
Compare ADCT & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- EBMT
- Stock Information
- Founded
- ADCT 2011
- EBMT 1922
- Country
- ADCT Switzerland
- EBMT United States
- Employees
- ADCT N/A
- EBMT N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- EBMT Major Banks
- Sector
- ADCT Health Care
- EBMT Finance
- Exchange
- ADCT Nasdaq
- EBMT Nasdaq
- Market Cap
- ADCT 127.9M
- EBMT 133.9M
- IPO Year
- ADCT 2020
- EBMT N/A
- Fundamental
- Price
- ADCT $1.28
- EBMT $17.49
- Analyst Decision
- ADCT Strong Buy
- EBMT
- Analyst Count
- ADCT 5
- EBMT 0
- Target Price
- ADCT $7.75
- EBMT N/A
- AVG Volume (30 Days)
- ADCT 235.3K
- EBMT 48.5K
- Earning Date
- ADCT 05-14-2025
- EBMT 04-29-2025
- Dividend Yield
- ADCT N/A
- EBMT 3.20%
- EPS Growth
- ADCT N/A
- EBMT 26.99
- EPS
- ADCT N/A
- EBMT 1.41
- Revenue
- ADCT $70,837,000.00
- EBMT $82,271,000.00
- Revenue This Year
- ADCT $6.82
- EBMT N/A
- Revenue Next Year
- ADCT $18.56
- EBMT $6.33
- P/E Ratio
- ADCT N/A
- EBMT $12.64
- Revenue Growth
- ADCT 1.84
- EBMT 0.06
- 52 Week Low
- ADCT $1.05
- EBMT $12.42
- 52 Week High
- ADCT $4.83
- EBMT $18.37
- Technical
- Relative Strength Index (RSI)
- ADCT 43.00
- EBMT 55.82
- Support Level
- ADCT $1.23
- EBMT $17.09
- Resistance Level
- ADCT $1.49
- EBMT $18.49
- Average True Range (ATR)
- ADCT 0.08
- EBMT 0.37
- MACD
- ADCT 0.00
- EBMT 0.05
- Stochastic Oscillator
- ADCT 25.00
- EBMT 44.44
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.